Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2025-04-25
DOI
https://doi.org/10.3389/fpsyt.2025.1501166
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

Julia Maruani, Éliane Albuisson, Thomas Schwitzer, Marie Moulard et al.
Frontiers in Psychiatry
Treatment of Major Depression
article

Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

Julia Maruani, Éliane Albuisson, Thomas Schwitzer, Marie Moulard, Pierre A. Geoffroy, Eve Cosker, Marie de Deus, Charlotte Petit, Naoual Mellouki Bendimred
article en

Abstract

No abstract available for this paper.
Frontiers in PsychiatryVol. 16
Inserm (FR), Délégation Paris 7 (FR), Université Paris Cité (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Hôpital Bichat-Claude-Bernard (FR), NeuroDiderot (FR)
Good health and well-being
Openalex Percentile: Top 90%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.